The global Hyperhidrosis Drugs market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
Botulinum Toxin Injections Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Hyperhidrosis Drugs include Allergan, GlaxoSmithKline, Journey Medical Corporation, Carpe, Duradry, BTXA, Seaford Pharmaceuticals and Robugen GmbH, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Hyperhidrosis Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hyperhidrosis Drugs. This report contains market size and forecasts of Hyperhidrosis Drugs in global, including the following market information:
Global Hyperhidrosis Drugs Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global top five companies in 2023 (%)
We surveyed the Hyperhidrosis Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hyperhidrosis Drugs Market, by Type, 2019-2024, 2025-2030 ($ millions)
Global Hyperhidrosis Drugs Market Segment Percentages, by Type, 2023 (%)
Botulinum Toxin Injections
Topical Medication
Oral Medication
Global Hyperhidrosis Drugs Market, by Application, 2019-2024, 2025-2030 ($ millions)
Global Hyperhidrosis Drugs Market Segment Percentages, by Application, 2023 (%)
Primary Focal Hyperhidrosis
Secondary Generalized Hyperhidrosis
Global Hyperhidrosis Drugs Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)
Global Hyperhidrosis Drugs Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hyperhidrosis Drugs revenues in global market, 2019-2024 (estimated), ($ millions)
Key companies Hyperhidrosis Drugs revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Allergan
GlaxoSmithKline
Journey Medical Corporation
Carpe
Duradry
BTXA
Seaford Pharmaceuticals
Robugen GmbH
Outline of Major Chapters:
Chapter 1: Introduces the definition of Hyperhidrosis Drugs, market overview.
Chapter 2: Global Hyperhidrosis Drugs market size in revenue.
Chapter 3: Detailed analysis of Hyperhidrosis Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Hyperhidrosis Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Hyperhidrosis Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Hyperhidrosis Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Hyperhidrosis Drugs Overall Market Size
2.1 Global Hyperhidrosis Drugs Market Size: 2023 VS 2030
2.2 Global Hyperhidrosis Drugs Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Hyperhidrosis Drugs Players in Global Market
3.2 Top Global Hyperhidrosis Drugs Companies Ranked by Revenue
3.3 Global Hyperhidrosis Drugs Revenue by Companies
3.4 Top 3 and Top 5 Hyperhidrosis Drugs Companies in Global Market, by Revenue in 2023
3.5 Global Companies Hyperhidrosis Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Hyperhidrosis Drugs Players in Global Market
3.6.1 List of Global Tier 1 Hyperhidrosis Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Hyperhidrosis Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Hyperhidrosis Drugs Market Size Markets, 2023 & 2030
4.1.2 Botulinum Toxin Injections
4.1.3 Topical Medication
4.1.4 Oral Medication
4.2 By Type - Global Hyperhidrosis Drugs Revenue & Forecasts
4.2.1 By Type - Global Hyperhidrosis Drugs Revenue, 2019-2024
4.2.2 By Type - Global Hyperhidrosis Drugs Revenue, 2025-2030
4.2.3 By Type - Global Hyperhidrosis Drugs Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Hyperhidrosis Drugs Market Size, 2023 & 2030
5.1.2 Primary Focal Hyperhidrosis
5.1.3 Secondary Generalized Hyperhidrosis
5.2 By Application - Global Hyperhidrosis Drugs Revenue & Forecasts
5.2.1 By Application - Global Hyperhidrosis Drugs Revenue, 2019-2024
5.2.2 By Application - Global Hyperhidrosis Drugs Revenue, 2025-2030
5.2.3 By Application - Global Hyperhidrosis Drugs Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Hyperhidrosis Drugs Market Size, 2023 & 2030
6.2 By Region - Global Hyperhidrosis Drugs Revenue & Forecasts
6.2.1 By Region - Global Hyperhidrosis Drugs Revenue, 2019-2024
6.2.2 By Region - Global Hyperhidrosis Drugs Revenue, 2025-2030
6.2.3 By Region - Global Hyperhidrosis Drugs Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Hyperhidrosis Drugs Revenue, 2019-2030
6.3.2 US Hyperhidrosis Drugs Market Size, 2019-2030
6.3.3 Canada Hyperhidrosis Drugs Market Size, 2019-2030
6.3.4 Mexico Hyperhidrosis Drugs Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Hyperhidrosis Drugs Revenue, 2019-2030
6.4.2 Germany Hyperhidrosis Drugs Market Size, 2019-2030
6.4.3 France Hyperhidrosis Drugs Market Size, 2019-2030
6.4.4 U.K. Hyperhidrosis Drugs Market Size, 2019-2030
6.4.5 Italy Hyperhidrosis Drugs Market Size, 2019-2030
6.4.6 Russia Hyperhidrosis Drugs Market Size, 2019-2030
6.4.7 Nordic Countries Hyperhidrosis Drugs Market Size, 2019-2030
6.4.8 Benelux Hyperhidrosis Drugs Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Hyperhidrosis Drugs Revenue, 2019-2030
6.5.2 China Hyperhidrosis Drugs Market Size, 2019-2030
6.5.3 Japan Hyperhidrosis Drugs Market Size, 2019-2030
6.5.4 South Korea Hyperhidrosis Drugs Market Size, 2019-2030
6.5.5 Southeast Asia Hyperhidrosis Drugs Market Size, 2019-2030
6.5.6 India Hyperhidrosis Drugs Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Hyperhidrosis Drugs Revenue, 2019-2030
6.6.2 Brazil Hyperhidrosis Drugs Market Size, 2019-2030
6.6.3 Argentina Hyperhidrosis Drugs Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Hyperhidrosis Drugs Revenue, 2019-2030
6.7.2 Turkey Hyperhidrosis Drugs Market Size, 2019-2030
6.7.3 Israel Hyperhidrosis Drugs Market Size, 2019-2030
6.7.4 Saudi Arabia Hyperhidrosis Drugs Market Size, 2019-2030
6.7.5 UAE Hyperhidrosis Drugs Market Size, 2019-2030
7 Hyperhidrosis Drugs Companies Profiles
7.1 Allergan
7.1.1 Allergan Company Summary
7.1.2 Allergan Business Overview
7.1.3 Allergan Hyperhidrosis Drugs Major Product Offerings
7.1.4 Allergan Hyperhidrosis Drugs Revenue in Global Market (2019-2024)
7.1.5 Allergan Key News & Latest Developments
7.2 GlaxoSmithKline
7.2.1 GlaxoSmithKline Company Summary
7.2.2 GlaxoSmithKline Business Overview
7.2.3 GlaxoSmithKline Hyperhidrosis Drugs Major Product Offerings
7.2.4 GlaxoSmithKline Hyperhidrosis Drugs Revenue in Global Market (2019-2024)
7.2.5 GlaxoSmithKline Key News & Latest Developments
7.3 Journey Medical Corporation
7.3.1 Journey Medical Corporation Company Summary
7.3.2 Journey Medical Corporation Business Overview
7.3.3 Journey Medical Corporation Hyperhidrosis Drugs Major Product Offerings
7.3.4 Journey Medical Corporation Hyperhidrosis Drugs Revenue in Global Market (2019-2024)
7.3.5 Journey Medical Corporation Key News & Latest Developments
7.4 Carpe
7.4.1 Carpe Company Summary
7.4.2 Carpe Business Overview
7.4.3 Carpe Hyperhidrosis Drugs Major Product Offerings
7.4.4 Carpe Hyperhidrosis Drugs Revenue in Global Market (2019-2024)
7.4.5 Carpe Key News & Latest Developments
7.5 Duradry
7.5.1 Duradry Company Summary
7.5.2 Duradry Business Overview
7.5.3 Duradry Hyperhidrosis Drugs Major Product Offerings
7.5.4 Duradry Hyperhidrosis Drugs Revenue in Global Market (2019-2024)
7.5.5 Duradry Key News & Latest Developments
7.6 BTXA
7.6.1 BTXA Company Summary
7.6.2 BTXA Business Overview
7.6.3 BTXA Hyperhidrosis Drugs Major Product Offerings
7.6.4 BTXA Hyperhidrosis Drugs Revenue in Global Market (2019-2024)
7.6.5 BTXA Key News & Latest Developments
7.7 Seaford Pharmaceuticals
7.7.1 Seaford Pharmaceuticals Company Summary
7.7.2 Seaford Pharmaceuticals Business Overview
7.7.3 Seaford Pharmaceuticals Hyperhidrosis Drugs Major Product Offerings
7.7.4 Seaford Pharmaceuticals Hyperhidrosis Drugs Revenue in Global Market (2019-2024)
7.7.5 Seaford Pharmaceuticals Key News & Latest Developments
7.8 Robugen GmbH
7.8.1 Robugen GmbH Company Summary
7.8.2 Robugen GmbH Business Overview
7.8.3 Robugen GmbH Hyperhidrosis Drugs Major Product Offerings
7.8.4 Robugen GmbH Hyperhidrosis Drugs Revenue in Global Market (2019-2024)
7.8.5 Robugen GmbH Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Hyperhidrosis Drugs Market Opportunities & Trends in Global Market
Table 2. Hyperhidrosis Drugs Market Drivers in Global Market
Table 3. Hyperhidrosis Drugs Market Restraints in Global Market
Table 4. Key Players of Hyperhidrosis Drugs in Global Market
Table 5. Top Hyperhidrosis Drugs Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Hyperhidrosis Drugs Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Hyperhidrosis Drugs Revenue Share by Companies, 2019-2024
Table 8. Global Companies Hyperhidrosis Drugs Product Type
Table 9. List of Global Tier 1 Hyperhidrosis Drugs Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hyperhidrosis Drugs Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Hyperhidrosis Drugs Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Hyperhidrosis Drugs Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Hyperhidrosis Drugs Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Hyperhidrosis Drugs Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Hyperhidrosis Drugs Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Hyperhidrosis Drugs Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Hyperhidrosis Drugs Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Hyperhidrosis Drugs Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Hyperhidrosis Drugs Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Hyperhidrosis Drugs Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Hyperhidrosis Drugs Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Hyperhidrosis Drugs Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Hyperhidrosis Drugs Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Hyperhidrosis Drugs Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Hyperhidrosis Drugs Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Hyperhidrosis Drugs Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Hyperhidrosis Drugs Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Hyperhidrosis Drugs Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Hyperhidrosis Drugs Revenue, (US$, Mn), 2025-2030
Table 30. Allergan Company Summary
Table 31. Allergan Hyperhidrosis Drugs Product Offerings
Table 32. Allergan Hyperhidrosis Drugs Revenue (US$, Mn) & (2019-2024)
Table 33. Allergan Key News & Latest Developments
Table 34. GlaxoSmithKline Company Summary
Table 35. GlaxoSmithKline Hyperhidrosis Drugs Product Offerings
Table 36. GlaxoSmithKline Hyperhidrosis Drugs Revenue (US$, Mn) & (2019-2024)
Table 37. GlaxoSmithKline Key News & Latest Developments
Table 38. Journey Medical Corporation Company Summary
Table 39. Journey Medical Corporation Hyperhidrosis Drugs Product Offerings
Table 40. Journey Medical Corporation Hyperhidrosis Drugs Revenue (US$, Mn) & (2019-2024)
Table 41. Journey Medical Corporation Key News & Latest Developments
Table 42. Carpe Company Summary
Table 43. Carpe Hyperhidrosis Drugs Product Offerings
Table 44. Carpe Hyperhidrosis Drugs Revenue (US$, Mn) & (2019-2024)
Table 45. Carpe Key News & Latest Developments
Table 46. Duradry Company Summary
Table 47. Duradry Hyperhidrosis Drugs Product Offerings
Table 48. Duradry Hyperhidrosis Drugs Revenue (US$, Mn) & (2019-2024)
Table 49. Duradry Key News & Latest Developments
Table 50. BTXA Company Summary
Table 51. BTXA Hyperhidrosis Drugs Product Offerings
Table 52. BTXA Hyperhidrosis Drugs Revenue (US$, Mn) & (2019-2024)
Table 53. BTXA Key News & Latest Developments
Table 54. Seaford Pharmaceuticals Company Summary
Table 55. Seaford Pharmaceuticals Hyperhidrosis Drugs Product Offerings
Table 56. Seaford Pharmaceuticals Hyperhidrosis Drugs Revenue (US$, Mn) & (2019-2024)
Table 57. Seaford Pharmaceuticals Key News & Latest Developments
Table 58. Robugen GmbH Company Summary
Table 59. Robugen GmbH Hyperhidrosis Drugs Product Offerings
Table 60. Robugen GmbH Hyperhidrosis Drugs Revenue (US$, Mn) & (2019-2024)
Table 61. Robugen GmbH Key News & Latest Developments
List of Figures
Figure 1. Hyperhidrosis Drugs Segment by Type in 2023
Figure 2. Hyperhidrosis Drugs Segment by Application in 2023
Figure 3. Global Hyperhidrosis Drugs Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Hyperhidrosis Drugs Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Hyperhidrosis Drugs Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Hyperhidrosis Drugs Revenue in 2023
Figure 8. By Type - Global Hyperhidrosis Drugs Revenue Market Share, 2019-2030
Figure 9. By Application - Global Hyperhidrosis Drugs Revenue Market Share, 2019-2030
Figure 10. By Type - Global Hyperhidrosis Drugs Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Hyperhidrosis Drugs Revenue Market Share, 2019-2030
Figure 12. By Application - Global Hyperhidrosis Drugs Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Hyperhidrosis Drugs Revenue Market Share, 2019-2030
Figure 14. By Region - Global Hyperhidrosis Drugs Revenue Market Share, 2019-2030
Figure 15. By Country - North America Hyperhidrosis Drugs Revenue Market Share, 2019-2030
Figure 16. US Hyperhidrosis Drugs Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Hyperhidrosis Drugs Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Hyperhidrosis Drugs Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Hyperhidrosis Drugs Revenue Market Share, 2019-2030
Figure 20. Germany Hyperhidrosis Drugs Revenue, (US$, Mn), 2019-2030
Figure 21. France Hyperhidrosis Drugs Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Hyperhidrosis Drugs Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Hyperhidrosis Drugs Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Hyperhidrosis Drugs Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Hyperhidrosis Drugs Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Hyperhidrosis Drugs Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Hyperhidrosis Drugs Revenue Market Share, 2019-2030
Figure 28. China Hyperhidrosis Drugs Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Hyperhidrosis Drugs Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Hyperhidrosis Drugs Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Hyperhidrosis Drugs Revenue, (US$, Mn), 2019-2030
Figure 32. India Hyperhidrosis Drugs Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Hyperhidrosis Drugs Revenue Market Share, 2019-2030
Figure 34. Brazil Hyperhidrosis Drugs Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Hyperhidrosis Drugs Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Hyperhidrosis Drugs Revenue Market Share, 2019-2030
Figure 37. Turkey Hyperhidrosis Drugs Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Hyperhidrosis Drugs Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Hyperhidrosis Drugs Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Hyperhidrosis Drugs Revenue, (US$, Mn), 2019-2030
Figure 41. Allergan Hyperhidrosis Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. GlaxoSmithKline Hyperhidrosis Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. Journey Medical Corporation Hyperhidrosis Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. Carpe Hyperhidrosis Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. Duradry Hyperhidrosis Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. BTXA Hyperhidrosis Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. Seaford Pharmaceuticals Hyperhidrosis Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. Robugen GmbH Hyperhidrosis Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
